116 related articles for article (PubMed ID: 10496841)
1. Low molecular weight heparins could be important in cancer.
Siragusa S
BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841
[No Abstract] [Full Text] [Related]
2. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
Bergqvist D
Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
[No Abstract] [Full Text] [Related]
3. A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data.
Topol EJ
Am Heart J; 2005 Apr; 149(4 Suppl):S100-6. PubMed ID: 16124950
[No Abstract] [Full Text] [Related]
4. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
[No Abstract] [Full Text] [Related]
5. Current use of low molecular weight heparins.
Donayre CE
Semin Vasc Surg; 1996 Dec; 9(4):362-71. PubMed ID: 8958613
[No Abstract] [Full Text] [Related]
6. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
7. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparins for DVT.
Ebell MH
J Fam Pract; 1994 Nov; 39(5):501-2. PubMed ID: 7964550
[No Abstract] [Full Text] [Related]
9. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
[No Abstract] [Full Text] [Related]
10. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
Caine GJ; Lip GY
Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
[No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient.
Kakkar AK
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():13-5. PubMed ID: 14730473
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
13. Therapy of unstable angina with the low molecular weight heparins.
Ageno W; Turpie AG
Vasc Med; 2000; 5(4):217-23. PubMed ID: 11213233
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulants and cancer survival.
Piccioli A; Falanga A; Prandoni P
Semin Thromb Hemost; 2006 Nov; 32(8):810-3. PubMed ID: 17171594
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
ten Cate-Hoek AJ; Prins MH
Thromb Res; 2008; 122(5):584-98. PubMed ID: 17996281
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin in the treatment of pulmonary embolism.
Ageno W; Turpie AG
Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
[TBL] [Abstract][Full Text] [Related]
17. Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboembolism?
Graber MA; Dachs R; Darby-Stewart A
Am Fam Physician; 2008 Jun; 77(11):1492-3. PubMed ID: 18581828
[No Abstract] [Full Text] [Related]
18. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
[No Abstract] [Full Text] [Related]
19. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
Wille-Jorgensen P
Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
[No Abstract] [Full Text] [Related]
20. [Do anticoagulants improve survival in patients with cancer?].
Meyer G
Pathol Biol (Paris); 2008 Jun; 56(4):233-8. PubMed ID: 18456421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
